Not checkedNot checked for notices yet.
Cancer Environment Immunotherapy: targeting TGF-β finds its way towards tissue healing and vasculature remodeling
Ke Jin, Fangfang Zhou, Long Zhang
Signal Transduction and Targeted Therapy · 2021
doi:10.1038/s41392-021-00472-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Recently, Prof. Ming O. Li and colleagues published two back-to-back studies in Nature , demonstrating that blocking transforming growth factor β (TGF-β) signaling in CD4 + T cells leads to tissue healing and remodeling of the blood vasculature, causing cancer cell hypoxia and death in distant avascular regions. 1 Furthermore, they also provide direct evidence validating that the above strategy does restrain cancer progression in a mouse model of breast cancer resistant to immune-checkpoint or anti-VEGF therapies. 2
Abstract licence: CC BY-NC-ND
References5
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.